(Q38047459)

27 August 2017

title

Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: lack of correlation with genotype (English)

1 reference

27 August 2017

Suzanne D DeBrosse

1

1 reference

27 August 2017

Kazuki Okajima

2

1 reference

27 August 2017

Shulin Zhang

3

1 reference

27 August 2017

Ghunwa Nakouzi

4

1 reference

27 August 2017

Christine L Schmotzer

5

1 reference

27 August 2017

Marilyn Lusk-Kopp

6

1 reference

27 August 2017

Mary Beth Frohnapfel

7

1 reference

27 August 2017

George Grahame

8

1 reference

27 August 2017

Douglas S Kerr

9

1 reference

27 August 2017

publication date

7 September 2012

1 reference

Molecular Genetics and Metabolism

27 August 2017

published in

1 reference

27 August 2017

volume

107

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

394-402

1 reference

Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Somatic mosaicism in a male with an exon skipping mutation in PDHA1 of the pyruvate dehydrogenase complex results in a milder phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Mutations of the E1beta subunit gene (PDHB) in four families with pyruvate dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Structural basis for flip-flop action of thiamin pyrophosphate-dependent enzymes revealed by human pyruvate dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Structural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Mutational study in the PDHA1 gene of 40 patients suspected of pyruvate dehydrogenase complex deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

A cognitively normal PDH-deficient 18-year-old man carrying the R263G mutation in the PDHA1 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Inactivation of the murine pyruvate dehydrogenase (Pdha1) gene and its effect on early embryonic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1 alpha deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1alpha subunit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

A deficiency of both subunits of pyruvate dehydrogenase which is not expressed in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

A mutation in the E1 alpha subunit of pyruvate dehydrogenase associated with variable expression of pyruvate dehydrogenase complex deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Pyruvate dehydrogenase E2 deficiency: a potentially treatable cause of episodic dystonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Pyruvate dehydrogenase E3 binding protein (protein X) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Pyruvate dehydrogenase phosphatase deficiency: identification of the first mutation in two brothers and restoration of activity by protein complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Pyruvate dehydrogenase phosphatase 1 (PDP1) null mutation produces a lethal infantile phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Thiamine Responsive Pyruvate Dehydrogenase Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

A zebrafish model for pyruvate dehydrogenase deficiency: rescue of neurological dysfunction and embryonic lethality using a ketogenic diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.09.001

10.1016/J.YMGME.2012.09.001

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference